The U.S. Department of Labor has issued a new rule requiring pharmacy benefit managers (PBMs) to disclose how they profit from employer-sponsored health plans, affecting about 136 million Americans. This transparency rule mandates PBMs to reveal payment deals with pharmacies and drugmakers, including drug rebates and spread pricing, which often increase drug costs. Employers will gain the power to audit PBMs annually to ensure accuracy and prevent overcharges, potentially lowering healthcare costs. The rule also extends disclosure requirements to third-party administrators and other service providers, signaling further transparency reforms ahead.
The new PBM transparency rule affecting 136 million Americans provides context for healthcare market activity. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 23:32 WIB: Out of 150 priced US health stocks, 118 rose and 31 fell. Notable movers include Baxter International Inc (BAX) at USD 24.00 with a 5.73% decline, Nuvation Bio Inc. Class A (NUVB) up 5.23% at USD 4.83, and Merck & Co., Inc. (MRK) at USD 148.00 with a 4.88% gain and balanced Pluang order activity of 50% sell and 50% buy.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
